SPARK Trial: New Treatment for Triple-Negative Breast Cancer
In the evolving landscape of cancer treatment, a pivotal study uncovers promising results involving the combination of Sitravatinib and Tislelizumab ...
In the evolving landscape of cancer treatment, a pivotal study uncovers promising results involving the combination of Sitravatinib and Tislelizumab ...
A groundbreaking phase II clinical trial named AXIOM is set to explore an innovative combination of stereotactic body radiotherapy (SBRT) ...
A groundbreaking clinical investigation has revealed a transformative approach in the management of recurrent prostate cancer presenting with limited metastatic ...
In a groundbreaking move towards improving breast cancer care accessibility, researchers have initiated a Phase II clinical trial comparing single-fraction ...
In the ever-evolving landscape of oncology, breakthrough treatments continue to reshape the prognosis of complex hematological malignancies. One such promising ...
In recent advancements within the realm of breast cancer therapy, the CompassHER2 pCR trial emerges as a beacon of hope ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine